WCRX

Warner Chilcott plcCIK 1323854 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for WCRX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for WCRX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Sullivan Ryan T	VP, General Counsel & Secr.	10	$0	$3.4K	2013-10-01
Rodriguez Rama Francisco	Senior V.P., Tech. Operations	14	$0	$11.0K	2013-10-01
Fenton Andrew	Senior V.P., CIO	25	$0	$91.3K	2013-10-01
Halstead Michael	Senior V.P., Corp. Development	29	$0	$109.8K	2013-10-01
Fuhrmann Rochelle	Senior V.P., Finance	25	$0	$103.5K	2013-10-01
Gilligan Claire A	Senior V.P., Quality	28	$0	$161.2K	2013-10-01
Boissonneault Roger M	CEO & President	24	$0	$1.36M	2013-10-01
Cross Leland H	Senior V.P., Tech. Operations	25	$0	$113.6K	2013-10-01
Ellman Herman	Senior V.P., Clinical Devel.	25	$0	$436.6K	2013-10-01
Herendeen Paul	Exec. V.P. and CFO	24	$0	$4.44M	2013-10-01
Howard Alvin D	Sr. V.P., Regulatory Affairs	26	$0	$2.08M	2013-10-01
KING JOHN A	Director	11	$0	$0	2013-10-01
BLOEM JAMES H	Director	9	$0	$0	2013-10-01
Vincze Leslie Stephan	SVP, Chief Compliance Officer	2	$0	$0	2013-09-30
O'Sullivan Patrick J	Director	9	$0	$0	2013-09-30
HOWSON TAMAR D	Director	4	$0	$0	2013-09-30
van Zoonen Marinus Johannes	President, Europe/Int'l & Mkt.	19	$0	$621.1K	2013-04-01
CONNAUGHTON JOHN	Director, 10% Owner	4	$0	$311.52M	2013-03-04
Hara Izumi	Sr. VP, Gen. Counsel & Sec.	9	$0	$1.74M	2012-12-31
Murray Stephen P	Director	3	$0	$315.77M	2012-11-28
Fitzgerald Liam M.	Director	1	$0	$0	2012-09-14
THL WC (Cayman), L.P.	10% Owner	1	$0	$183.40M	2012-09-11
Bain Capital Integral Investors II, L.P.	10% Owner	1	$0	$168.86M	2012-09-11
ABBRECHT TODD M	Director	1	$0	$183.40M	2012-09-11
JPMP MASTER FUND MANAGER L P	10% Owner	10	$0	$376.79M	2012-09-11
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP	10% Owner	10	$0	$376.79M	2012-09-11
BAIN CAPITAL INVESTORS LLC	10% Owner	1	$0	$0	2012-09-05
Fawzi Mahdi B	President, Research & Develop.	1	$0	$0	2011-12-31
Bruno Anthony D	Exec. V.P., Corp. Development	1	$0	$0	2011-12-31
Reichel Carl W	President, Pharmaceuticals	1	$0	$0	2011-12-31

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer	2013-10-01	2013-10-01	18,040	—	$0	0	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	D To issuer	2013-10-01	2013-10-01	22,109	—	$0	0	SEC↗
KING JOHN A	Director	D To issuer	2013-10-01	2013-10-01	1,354,046	—	$0	0	SEC↗
BLOEM JAMES H	Director	D To issuer	2013-10-01	2013-10-01	24,176	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer	2013-10-01	2013-10-01	84,219	—	$0	0	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer	2013-10-01	2013-10-01	94,900	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer	2013-10-01	2013-10-01	36,370	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer	2013-10-01	2013-10-01	300,000	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer	2013-10-01	2013-10-01	2,195,498	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer	2013-10-01	2013-10-01	165,753	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer	2013-10-01	2013-10-01	28,049	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer	2013-10-01	2013-10-01	62,162	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer	2013-10-01	2013-10-01	189,356	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer	2013-10-01	2013-10-01	41,076	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer	2013-10-01	2013-10-01	92,840	—	$0	0	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer deriv	2013-09-30	2013-10-01	8,170	—	$0	0	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer deriv	2013-09-30	2013-10-01	2,193	—	$0	0	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer deriv	2013-09-30	2013-10-01	1,065	—	$0	0	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer deriv	2013-09-30	2013-10-01	6,610	—	$0	0	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer deriv	2013-09-30	2013-10-01	15,730	—	$0	0	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer deriv	2013-09-30	2013-10-01	28,860	—	$0	0	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer deriv	2013-09-30	2013-10-01	8,990	—	$0	0	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	D To issuer deriv	2013-09-30	2013-10-01	13,150	—	$0	0	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	D To issuer deriv	2013-09-30	2013-10-01	16,590	—	$0	0	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	D To issuer deriv	2013-09-30	2013-10-01	13,680	—	$0	0	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	D To issuer deriv	2013-09-30	2013-10-01	28,860	—	$0	0	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	D To issuer deriv	2013-09-30	2013-10-01	15,430	—	$0	0	SEC↗
O'Sullivan Patrick J	Director	D To issuer deriv	2013-09-30	2013-10-01	15,300	—	$0	0	SEC↗
O'Sullivan Patrick J	Director	D To issuer deriv	2013-09-30	2013-10-01	14,680	—	$0	0	SEC↗
O'Sullivan Patrick J	Director	D To issuer deriv	2013-09-30	2013-10-01	28,660	—	$0	0	SEC↗
O'Sullivan Patrick J	Director	D To issuer deriv	2013-09-30	2013-10-01	9,640	—	$0	0	SEC↗
O'Sullivan Patrick J	Director	D To issuer deriv	2013-09-30	2013-10-01	10,100	—	$0	0	SEC↗
KING JOHN A	Director	D To issuer deriv	2013-09-30	2013-10-01	14,680	—	$0	0	SEC↗
KING JOHN A	Director	D To issuer deriv	2013-09-30	2013-10-01	28,660	—	$0	0	SEC↗
KING JOHN A	Director	D To issuer deriv	2013-09-30	2013-10-01	10,100	—	$0	0	SEC↗
KING JOHN A	Director	D To issuer deriv	2013-09-30	2013-10-01	9,640	—	$0	0	SEC↗
KING JOHN A	Director	D To issuer deriv	2013-09-30	2013-10-01	1,341	—	$0	0	SEC↗
KING JOHN A	Director	D To issuer deriv	2013-09-30	2013-10-01	15,300	—	$0	0	SEC↗
BLOEM JAMES H	Director	D To issuer deriv	2013-09-30	2013-10-01	9,640	—	$0	0	SEC↗
BLOEM JAMES H	Director	D To issuer deriv	2013-09-30	2013-10-01	10,100	—	$0	0	SEC↗
BLOEM JAMES H	Director	D To issuer deriv	2013-09-30	2013-10-01	14,680	—	$0	0	SEC↗
BLOEM JAMES H	Director	D To issuer deriv	2013-09-30	2013-10-01	28,660	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer deriv	2013-09-30	2013-10-01	19,100	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer deriv	2013-09-30	2013-10-01	26,050	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer deriv	2013-09-30	2013-10-01	15,040	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer deriv	2013-09-30	2013-10-01	34,260	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer deriv	2013-09-30	2013-10-01	16,020	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer deriv	2013-09-30	2013-10-01	16,500	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer deriv	2013-09-30	2013-10-01	15,020	—	$0	0	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer deriv	2013-09-30	2013-10-01	53,050	—	$0	0	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer deriv	2013-09-30	2013-10-01	479,430	—	$0	0	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer deriv	2013-09-30	2013-10-01	111,920	—	$0	0	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer deriv	2013-09-30	2013-10-01	56,710	—	$0	0	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer deriv	2013-09-30	2013-10-01	49,180	—	$0	0	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer deriv	2013-09-30	2013-10-01	73,330	—	$0	0	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer deriv	2013-09-30	2013-10-01	129,340	—	$0	0	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer deriv	2013-09-30	2013-10-01	36,610	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	53,050	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	26,050	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	10,340	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	6,203	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	9,280	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	1,463	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	6,790	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	1,945	—	$0	0	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer deriv	2013-09-30	2013-10-01	15,020	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer deriv	2013-09-30	2013-10-01	216,810	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer deriv	2013-09-30	2013-10-01	380,960	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer deriv	2013-09-30	2013-10-01	479,430	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer deriv	2013-09-30	2013-10-01	113,680	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer deriv	2013-09-30	2013-10-01	401,640	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer deriv	2013-09-30	2013-10-01	211,740	—	$0	0	SEC↗
Boissonneault Roger M	CEO & President	D To issuer deriv	2013-09-30	2013-10-01	143,240	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer deriv	2013-09-30	2013-10-01	32,710	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer deriv	2013-09-30	2013-10-01	53,050	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer deriv	2013-09-30	2013-10-01	17,190	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer deriv	2013-09-30	2013-10-01	26,050	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer deriv	2013-09-30	2013-10-01	15,020	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer deriv	2013-09-30	2013-10-01	13,500	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer deriv	2013-09-30	2013-10-01	14,560	—	$0	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer deriv	2013-09-30	2013-10-01	15,040	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	19,100	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	15,020	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	10,000	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	10,590	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	19,020	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	9,080	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	5,330	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	26,050	—	$0	0	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer deriv	2013-09-30	2013-10-01	53,050	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer deriv	2013-09-30	2013-10-01	14,560	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer deriv	2013-09-30	2013-10-01	13,500	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer deriv	2013-09-30	2013-10-01	17,190	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer deriv	2013-09-30	2013-10-01	15,040	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer deriv	2013-09-30	2013-10-01	29,590	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer deriv	2013-09-30	2013-10-01	26,050	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer deriv	2013-09-30	2013-10-01	15,020	—	$0	0	SEC↗
Cross Leland H	Senior V.P.	D To issuer deriv	2013-09-30	2013-10-01	53,050	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer deriv	2013-09-30	2013-10-01	53,050	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer deriv	2013-09-30	2013-10-01	15,020	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer deriv	2013-09-30	2013-10-01	5,400	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer deriv	2013-09-30	2013-10-01	7,070	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer deriv	2013-09-30	2013-10-01	13,580	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer deriv	2013-09-30	2013-10-01	7,260	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer deriv	2013-09-30	2013-10-01	19,100	—	$0	0	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer deriv	2013-09-30	2013-10-01	26,050	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer deriv	2013-09-30	2013-10-01	9,630	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer deriv	2013-09-30	2013-10-01	53,050	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer deriv	2013-09-30	2013-10-01	9,080	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer deriv	2013-09-30	2013-10-01	17,330	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer deriv	2013-09-30	2013-10-01	26,050	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer deriv	2013-09-30	2013-10-01	10,340	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer deriv	2013-09-30	2013-10-01	10,000	—	$0	0	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer deriv	2013-09-30	2013-10-01	15,020	—	$0	0	SEC↗
HOWSON TAMAR D	Director	D To issuer deriv	2013-09-30	2013-10-01	14,680	—	$0	0	SEC↗
Vincze Leslie Stephan	SVP, Chief Compliance Office	D To issuer	2013-09-30	2013-10-01	32,980	—	$0	0	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	D To issuer	2013-09-30	2013-10-01	8,420	—	$0	18,040	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	D To issuer	2013-09-30	2013-10-01	13,550	—	$0	22,109	SEC↗
O'Sullivan Patrick J	Director	D To issuer	2013-09-30	2013-10-01	4,170	—	$0	0	SEC↗
KING JOHN A	Director	D To issuer	2013-09-30	2013-10-01	4,170	—	$0	0	SEC↗
BLOEM JAMES H	Director	D To issuer	2013-09-30	2013-10-01	4,170	—	$0	24,176	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	D To issuer	2013-09-30	2013-10-01	15,470	—	$0	84,219	SEC↗
Herendeen Paul	Exec. V.P. and CFO	D To issuer	2013-09-30	2013-10-01	37,720	—	$0	94,900	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	D To issuer	2013-09-30	2013-10-01	15,470	—	$0	36,370	SEC↗
Boissonneault Roger M	CEO & President	D To issuer	2013-09-30	2013-10-01	117,120	—	$0	2,195,498	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	D To issuer	2013-09-30	2013-10-01	15,470	—	$0	165,753	SEC↗
Gilligan Claire A	Senior V.P., Quality	D To issuer	2013-09-30	2013-10-01	15,470	—	$0	62,162	SEC↗
Cross Leland H	Senior V.P.	D To issuer	2013-09-30	2013-10-01	15,470	—	$0	189,356	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	D To issuer	2013-09-30	2013-10-01	15,470	—	$0	41,076	SEC↗
Fenton Andrew	Senior V.P., CIO	D To issuer	2013-09-30	2013-10-01	15,470	—	$0	92,840	SEC↗
HOWSON TAMAR D	Director	D To issuer	2013-09-30	2013-10-01	4,170	—	$0	0	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	A Award deriv	2013-07-01	2013-07-02	15,430	—	$0	15,430	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	A Award deriv	2013-07-01	2013-07-02	4,980	—	$0	13,150	SEC↗
Sullivan Ryan T	VP, General Counsel & Secr.	S Sale	2013-07-01	2013-07-02	169	$19.88	$3.4K	26,460	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2013-07-01	2013-07-02	366	$19.88	$7.3K	51,840	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	A Award	2013-07-01	2013-07-02	5,130	—	$0	35,659	SEC↗
Vincze Leslie Stephan	SVP, Chief Compliance Office	A Award	2013-07-01	2013-07-02	32,980	—	$0	32,980	SEC↗
BLOEM JAMES H	Director	A Award deriv	2013-05-07	2013-05-09	14,680	—	$0	14,680	SEC↗
O'Sullivan Patrick J	Director	A Award deriv	2013-05-07	2013-05-09	14,680	—	$0	14,680	SEC↗
HOWSON TAMAR D	Director	A Award deriv	2013-05-07	2013-05-09	14,680	—	$0	14,680	SEC↗
KING JOHN A	Director	A Award deriv	2013-05-07	2013-05-09	14,680	—	$0	14,680	SEC↗
BLOEM JAMES H	Director	A Award	2013-05-07	2013-05-09	4,170	—	$0	28,346	SEC↗
O'Sullivan Patrick J	Director	A Award	2013-05-07	2013-05-09	4,170	—	$0	4,170	SEC↗
HOWSON TAMAR D	Director	A Award	2013-05-07	2013-05-09	4,170	—	$0	4,170	SEC↗
KING JOHN A	Director	A Award	2013-05-07	2013-05-09	4,170	—	$0	4,170	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2013-04-01	2013-04-01	703	$13.41	$9.4K	144,838	SEC↗
CONNAUGHTON JOHN	Director	J Other	2013-03-04	2013-03-06	901,014	—	$0	10,590,608	SEC↗
CONNAUGHTON JOHN	Director	S Sale	2013-03-04	2013-03-06	10,590,608	$13.47	$142.66M	0	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	S Sale	2013-03-01	2013-03-04	1,666	$13.38	$22.3K	181,223	SEC↗
Boissonneault Roger M	CEO & President	S Sale	2013-02-28	2013-03-01	18,730	$13.46	$252.1K	2,312,618	SEC↗
Herendeen Paul	Exec. V.P. and CFO	S Sale	2013-02-28	2013-03-01	4,674	$13.46	$62.9K	132,620	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	S Sale	2013-02-28	2013-03-01	1,728	$13.46	$23.3K	56,546	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2013-02-28	2013-03-01	1,747	$13.46	$23.5K	52,206	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	S Sale	2013-02-28	2013-03-01	1,728	$13.46	$23.3K	99,689	SEC↗
Fenton Andrew	Senior V.P., CIO	S Sale	2013-02-28	2013-03-01	1,390	$13.46	$18.7K	108,310	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	S Sale	2013-02-28	2013-03-01	1,324	$13.46	$17.8K	204,826	SEC↗
Gilligan Claire A	Senior V.P., Quality	S Sale	2013-02-28	2013-03-01	2,354	$13.46	$31.7K	77,632	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	S Sale	2013-02-28	2013-03-01	820	$13.46	$11.0K	30,529	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2013-02-28	2013-03-01	15,869	$13.46	$213.6K	145,541	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	M Exercise deriv	2013-02-27	2013-03-01	26,767	—	$0	80,303	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	M Exercise deriv	2013-02-27	2013-03-01	4,970	—	$0	9,940	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	M Exercise	2013-02-27	2013-03-01	26,767	—	$0	161,410	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	M Exercise	2013-02-27	2013-03-01	4,970	—	$0	134,643	SEC↗
Boissonneault Roger M	CEO & President	S Sale	2013-02-19	2013-02-21	7,928	$14.53	$115.2K	2,331,348	SEC↗
Herendeen Paul	Exec. V.P. and CFO	S Sale	2013-02-19	2013-02-21	1,969	$14.53	$28.6K	137,294	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2013-02-19	2013-02-21	419	$14.53	$6.1K	53,953	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	S Sale	2013-02-19	2013-02-21	767	$14.53	$11.1K	58,274	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2013-02-19	2013-02-21	2,562	$14.53	$37.2K	129,673	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	S Sale	2013-02-19	2013-02-21	767	$14.53	$11.1K	101,417	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	S Sale	2013-02-19	2013-02-21	553	$14.53	$8.0K	206,150	SEC↗
Gilligan Claire A	Senior V.P., Quality	S Sale	2013-02-19	2013-02-21	1,045	$14.53	$15.2K	79,986	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	S Sale	2013-02-19	2013-02-21	691	$14.53	$10.0K	182,889	SEC↗
Fenton Andrew	Senior V.P., CIO	S Sale	2013-02-19	2013-02-21	419	$14.53	$6.1K	109,700	SEC↗
Boissonneault Roger M	CEO & President	A Award deriv	2013-02-13	2013-02-15	401,640	—	$0	401,640	SEC↗
Boissonneault Roger M	CEO & President	A Award deriv	2013-02-13	2013-02-15	113,680	—	$0	113,680	SEC↗
Herendeen Paul	Exec. V.P. and CFO	A Award deriv	2013-02-13	2013-02-15	129,340	—	$0	129,340	SEC↗
Herendeen Paul	Exec. V.P. and CFO	A Award deriv	2013-02-13	2013-02-15	36,610	—	$0	36,610	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	A Award deriv	2013-02-13	2013-02-15	15,020	—	$0	15,020	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	A Award deriv	2013-02-13	2013-02-15	53,050	—	$0	53,050	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	A Award deriv	2013-02-13	2013-02-15	53,050	—	$0	53,050	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	A Award deriv	2013-02-13	2013-02-15	15,020	—	$0	15,020	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	A Award deriv	2013-02-13	2013-02-15	15,020	—	$0	15,020	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	A Award deriv	2013-02-13	2013-02-15	53,050	—	$0	53,050	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	A Award deriv	2013-02-13	2013-02-15	53,050	—	$0	53,050	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	A Award deriv	2013-02-13	2013-02-15	15,020	—	$0	15,020	SEC↗
Fenton Andrew	Senior V.P., CIO	A Award deriv	2013-02-13	2013-02-15	15,020	—	$0	15,020	SEC↗
Fenton Andrew	Senior V.P., CIO	A Award deriv	2013-02-13	2013-02-15	53,050	—	$0	53,050	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	A Award deriv	2013-02-13	2013-02-15	53,050	—	$0	53,050	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	A Award deriv	2013-02-13	2013-02-15	15,020	—	$0	15,020	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	A Award deriv	2013-02-13	2013-02-15	28,860	—	$0	28,860	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	A Award deriv	2013-02-13	2013-02-15	8,170	—	$0	8,170	SEC↗
Gilligan Claire A	Senior V.P., Quality	A Award deriv	2013-02-13	2013-02-15	53,050	—	$0	53,050	SEC↗
Gilligan Claire A	Senior V.P., Quality	A Award deriv	2013-02-13	2013-02-15	15,020	—	$0	15,020	SEC↗
Boissonneault Roger M	CEO & President	A Award	2013-02-13	2013-02-15	117,120	—	$0	2,339,276	SEC↗
Herendeen Paul	Exec. V.P. and CFO	A Award	2013-02-13	2013-02-15	37,720	—	$0	139,263	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	A Award	2013-02-13	2013-02-15	15,470	—	$0	54,372	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	A Award	2013-02-13	2013-02-15	15,470	—	$0	59,041	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	A Award	2013-02-13	2013-02-15	15,470	—	$0	206,703	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	A Award	2013-02-13	2013-02-15	15,470	—	$0	183,580	SEC↗
Fenton Andrew	Senior V.P., CIO	A Award	2013-02-13	2013-02-15	15,470	—	$0	110,119	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	A Award	2013-02-13	2013-02-15	15,470	—	$0	102,184	SEC↗
Rodriguez Rama Francisco	Senior V.P., Tech. Operation	A Award	2013-02-13	2013-02-15	8,420	—	$0	31,349	SEC↗
Gilligan Claire A	Senior V.P., Quality	A Award	2013-02-13	2013-02-15	15,470	—	$0	81,031	SEC↗
Boissonneault Roger M	CEO & President	S Sale	2013-02-01	2013-02-04	9,125	$14.18	$129.4K	2,222,156	SEC↗
Herendeen Paul	Exec. V.P. and CFO	S Sale	2013-02-01	2013-02-04	2,840	$14.18	$40.3K	101,543	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2013-02-01	2013-02-04	13,790	$14.18	$195.5K	132,235	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	S Sale	2013-02-01	2013-02-04	998	$14.18	$14.2K	43,571	SEC↗
Gilligan Claire A	Senior V.P., Quality	S Sale	2013-02-01	2013-02-04	1,377	$14.18	$19.5K	65,561	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	S Sale	2013-02-01	2013-02-04	1,010	$14.18	$14.3K	86,714	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2013-02-01	2013-02-04	998	$14.18	$14.2K	38,902	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	S Sale	2013-02-01	2013-02-04	1,010	$14.18	$14.3K	168,110	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	S Sale	2013-02-01	2013-02-04	808	$14.18	$11.5K	191,233	SEC↗
Fenton Andrew	Senior V.P., CIO	S Sale	2013-02-01	2013-02-04	996	$14.18	$14.1K	94,649	SEC↗
Boissonneault Roger M	CEO & President	S Sale	2013-01-30	2013-01-31	8,470	$13.38	$113.3K	2,231,281	SEC↗
Herendeen Paul	Exec. V.P. and CFO	S Sale	2013-01-30	2013-01-31	2,208	$13.38	$29.5K	104,383	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2013-01-30	2013-01-31	1,907	$14.42	$27.5K	146,333	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2013-01-30	2013-01-31	308	$13.38	$4.1K	146,025	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2013-01-30	2013-01-31	320	$13.38	$4.3K	39,900	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	S Sale	2013-01-30	2013-01-31	282	$13.38	$3.8K	44,569	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	S Sale	2013-01-30	2013-01-31	591	$13.38	$7.9K	87,724	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	S Sale	2013-01-30	2013-01-31	586	$13.38	$7.8K	169,120	SEC↗
Fenton Andrew	Senior V.P., CIO	S Sale	2013-01-30	2013-01-31	351	$13.38	$4.7K	95,645	SEC↗
Gilligan Claire A	Senior V.P., Quality	S Sale	2013-01-30	2013-01-31	489	$13.38	$6.5K	66,938	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	S Sale	2013-01-30	2013-01-31	465	$13.38	$6.2K	192,041	SEC↗
Boissonneault Roger M	CEO & President	S Sale	2013-01-22	2013-01-23	13,924	$13.50	$188.0K	2,239,751	SEC↗
Herendeen Paul	Exec. V.P. and CFO	S Sale	2013-01-22	2013-01-23	4,305	$13.50	$58.1K	106,591	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2013-01-22	2013-01-23	488	$13.50	$6.6K	40,220	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	S Sale	2013-01-22	2013-01-23	488	$13.50	$6.6K	44,851	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	S Sale	2013-01-22	2013-01-23	839	$13.50	$11.3K	192,506	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	S Sale	2013-01-22	2013-01-23	1,222	$13.50	$16.5K	88,315	SEC↗
Gilligan Claire A	Senior V.P., Quality	S Sale	2013-01-22	2013-01-23	949	$13.50	$12.8K	67,427	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	S Sale	2013-01-22	2013-01-23	1,166	$13.50	$15.7K	169,706	SEC↗
Fenton Andrew	Senior V.P., CIO	S Sale	2013-01-22	2013-01-23	621	$13.50	$8.4K	95,996	SEC↗
Hara Izumi	Senior V.P.	D To issuer	2012-12-31	2013-01-02	30,859	—	$0	43,026	SEC↗
Murray Stephen P	Director	S Sale	2012-11-28	2012-11-30	6,491,618	$11.41	$74.07M	0	SEC↗
Murray Stephen P	Director	S Sale	2012-11-20	2012-11-20	5,000,000	$11.66	$58.30M	6,491,618	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2012-10-01	2012-10-01	77	$13.55	$1.0K	40,708	SEC↗
Gilligan Claire A	Senior V.P., Quality	S Sale	2012-10-01	2012-10-01	264	$13.55	$3.6K	68,376	SEC↗
BLOEM JAMES H	Director	A Award deriv	2012-09-14	2012-09-18	28,660	—	$0	28,660	SEC↗
KING JOHN A	Director	A Award deriv	2012-09-14	2012-09-18	28,660	—	$0	28,660	SEC↗
Fitzgerald Liam M.	Director	A Award deriv	2012-09-14	2012-09-18	28,660	—	$0	28,660	SEC↗
O'Sullivan Patrick J	Director	A Award deriv	2012-09-14	2012-09-18	28,660	—	$0	28,660	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	215,401	$13.10	$2.82M	176,805	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	2,224,741	$13.10	$29.14M	1,826,134	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	373,782	$13.10	$4.90M	306,811	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	266,987	$13.10	$3.50M	219,149	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	1,145,303	$13.10	$15.00M	940,099	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	7,894,814	$13.10	$103.42M	6,480,306	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	14,000,000	$13.10	$183.40M	11,491,618	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	1,497,803	$13.10	$19.62M	675,209	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	950,124	$13.10	$12.45M	779,889	SEC↗
J P MORGAN PARTNERS GLOBAL INV	10% Owner	S Sale	2012-09-11	2012-09-11	193,470	$13.10	$2.53M	87,216	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	14,000,000	$13.10	$183.40M	11,491,618	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	1,497,803	$13.10	$19.62M	675,209	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	215,401	$13.10	$2.82M	176,805	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	950,124	$13.10	$12.45M	779,889	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	193,470	$13.10	$2.53M	87,216	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	1,145,303	$13.10	$15.00M	940,099	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	266,987	$13.10	$3.50M	219,149	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	373,782	$13.10	$4.90M	306,811	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	2,224,741	$13.10	$29.14M	1,826,134	SEC↗
JPMP MASTER FUND MANAGER L P	10% Owner	S Sale	2012-09-11	2012-09-11	7,894,814	$13.10	$103.42M	6,480,306	SEC↗
Murray Stephen P	Director	S Sale	2012-09-11	2012-09-12	14,000,000	$13.10	$183.40M	11,491,618	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	S Sale	2012-09-11	2012-09-12	23,500	$13.10	$307.9K	170,872	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	S Sale	2012-09-11	2012-09-12	147,639	$13.10	$1.93M	89,537	SEC↗
Herendeen Paul	Exec. V.P. and CFO	S Sale	2012-09-11	2012-09-12	309,240	$13.10	$4.05M	110,896	SEC↗
Hara Izumi	Senior V.P.	S Sale	2012-09-11	2012-09-12	126,993	$13.10	$1.66M	73,885	SEC↗
ABBRECHT TODD M	Director	S Sale	2012-09-11	2012-09-13	14,000,000	$13.10	$183.40M	11,491,622	SEC↗
THL WC (Cayman), L.P.	10% Owner	S Sale	2012-09-11	2012-09-13	14,000,000	$13.10	$183.40M	11,491,622	SEC↗
CONNAUGHTON JOHN	Director, 10% Owner	S Sale	2012-09-11	2012-09-13	12,890,449	$13.10	$168.86M	11,491,622	SEC↗
Bain Capital Integral Investor	10% Owner	S Sale	2012-09-11	2012-09-13	12,890,449	$13.10	$168.86M	11,491,622	SEC↗
CONNAUGHTON JOHN	Director, 10% Owner	J Other	2012-09-05	2012-09-07	1,109,551	—	$0	24,382,071	SEC↗
BAIN CAPITAL INVESTORS LLC	10% Owner	J Other	2012-09-05	2012-09-07	1,109,551	—	$0	24,382,071	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2012-07-02	2012-07-02	355	$17.96	$6.4K	40,785	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2012-04-02	2012-04-03	703	$16.95	$11.9K	148,240	SEC↗
Boissonneault Roger M	CEO & President	S Sale	2012-03-01	2012-03-02	5,320	$17.00	$90.4K	2,253,675	SEC↗
Herendeen Paul	Exec. V.P. and CFO	S Sale	2012-03-01	2012-03-02	1,827	$17.00	$31.1K	420,136	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2012-03-01	2012-03-02	2,485	$17.00	$42.2K	148,943	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2012-03-01	2012-03-02	725	$17.00	$12.3K	41,140	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	S Sale	2012-03-01	2012-03-02	710	$17.00	$12.1K	45,339	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	S Sale	2012-03-01	2012-03-02	710	$17.00	$12.1K	237,176	SEC↗
Hara Izumi	Sr. VP, Gen. Counsel & Sec.	S Sale	2012-03-01	2012-03-02	710	$17.00	$12.1K	200,878	SEC↗
Gilligan Claire A	Senior V.P., Quality	S Sale	2012-03-01	2012-03-02	973	$17.00	$16.5K	68,640	SEC↗
Fenton Andrew	Senior V.P., CIO	S Sale	2012-03-01	2012-03-02	386	$17.00	$6.6K	96,617	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	S Sale	2012-03-01	2012-03-02	558	$17.00	$9.5K	193,345	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	M Exercise deriv	2012-02-29	2012-03-02	4,970	—	$0	14,910	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	M Exercise	2012-02-29	2012-03-02	4,970	—	$0	151,428	SEC↗
Boissonneault Roger M	CEO & President	S Sale	2012-02-21	2012-02-23	5,628	$16.82	$94.7K	2,258,995	SEC↗
Herendeen Paul	Exec. V.P. and CFO	S Sale	2012-02-21	2012-02-23	1,933	$16.82	$32.5K	421,963	SEC↗
van Zoonen Marinus Johannes	President, Europe/Int'l & Mk	S Sale	2012-02-21	2012-02-23	2,561	$16.82	$43.1K	146,458	SEC↗
Halstead Michael	Senior V.P., Corp. Developme	S Sale	2012-02-21	2012-02-23	409	$16.82	$6.9K	41,865	SEC↗
Ellman Herman	Senior V.P., Clinical Devel.	S Sale	2012-02-21	2012-02-23	677	$16.82	$11.4K	194,372	SEC↗
Fuhrmann Rochelle	Senior V.P., Finance	S Sale	2012-02-21	2012-02-23	752	$16.82	$12.6K	46,049	SEC↗
Cross Leland H	Senior V.P., Tech. Operation	S Sale	2012-02-21	2012-02-23	590	$16.82	$9.9K	193,903	SEC↗
Howard Alvin D	Sr. V.P., Regulatory Affairs	S Sale	2012-02-21	2012-02-23	752	$16.82	$12.6K	237,886	SEC↗
Hara Izumi	Sr. VP, Gen. Counsel & Sec.	S Sale	2012-02-21	2012-02-23	752	$16.82	$12.6K	201,588	SEC↗
Gilligan Claire A	Senior V.P., Quality	S Sale	2012-02-21	2012-02-23	1,030	$16.82	$17.3K	69,613	SEC↗
Fenton Andrew	Senior V.P., CIO	S Sale	2012-02-21	2012-02-23	409	$16.82	$6.9K	97,003	SEC↗
Boissonneault Roger M	CEO & President	A Award deriv	2012-01-31	2012-02-02	211,740	—	$0	211,740	SEC↗
Herendeen Paul	Exec. V.P. and CFO	A Award deriv	2012-01-31	2012-02-02	73,330	—	$0	73,330	SEC↗